Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 13, 2014Current Opinion in Endocrinology Diabetes and ObesityOpen Access

How sensitive (second-generation) thyroglobulin measurement is changing paradigms for monitoring patients with differentiated thyroid cancer, in the absence or presence of thyroglobulin autoantibodies

View Full Paper
Ask AI
Bookmark
Share

Authors

CSCarole A. SpencerSouth Australia PathologyJLJonathan S. LoPrestiUniversity of Southern CaliforniaSFShireen FatemiKaiser Permanente

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Spencer et al. (2014) studied this question.

synapsesocial.com/papers/6a088c24ad370a6b44de2bd7https://doi.org/10.1097/med.0000000000000092
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1DIAGNOSIS OF ENDOCRINE DISEASE: Thyroglobulin measurement using highly sensitive assays in patients with differentiated thyroid cancer: a clinical position paper2014 · 112 citations
  2. 2Implications of Thyroglobulin Antibody Positivity in Patients with Differentiated Thyroid Cancer: A Clinical Position Statement2013 · 190 citations
  3. 3Phantoms in the Assay Tube: Heterophile Antibody Interferences in Serum Thyroglobulin Assays2003 · 197 citations
  4. 4The Behavior of Autologous Thyroglobulin in the Circulation of Rabbits Immunized with Either Heterologous or Altered Homologous Thyroglobulin1967 · 51 citations
  5. 5Long-term variability in serum thyroglobulin and thyroid related hormones in healthy subjects1980 · 74 citations